FR2389376A1 - Veterinary use of sodium cromoglycate and analogues - for treating and preventing allergic respiratory and gastrointestinal disorders - Google Patents

Veterinary use of sodium cromoglycate and analogues - for treating and preventing allergic respiratory and gastrointestinal disorders

Info

Publication number
FR2389376A1
FR2389376A1 FR7813350A FR7813350A FR2389376A1 FR 2389376 A1 FR2389376 A1 FR 2389376A1 FR 7813350 A FR7813350 A FR 7813350A FR 7813350 A FR7813350 A FR 7813350A FR 2389376 A1 FR2389376 A1 FR 2389376A1
Authority
FR
France
Prior art keywords
pigs
calves
treating
gastrointestinal disorders
analogues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7813350A
Other languages
French (fr)
Other versions
FR2389376B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB1899577A external-priority patent/GB1592968A/en
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of FR2389376A1 publication Critical patent/FR2389376A1/en
Application granted granted Critical
Publication of FR2389376B1 publication Critical patent/FR2389376B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Feed For Specific Animals (AREA)
  • Medicinal Preparation (AREA)

Abstract

Prophylactic and curative treatment of allergic disorders in cats, dogs, pigs, horses and cattle comprises administering a cpd. having activity similar to that of sodium cromoglycate, esp. one of formula (I) or one of their salts (where X is a 3-7C polymethylene chain opt. substd. by OH). Cpds. are used for the relief or prevention of respiratory and pulmonary disorders, neonatal diarrhoea in pigs and calves etc. Pref. dose is 40-80 mg daily by inhalation in calves and pigs. For gastrointestinal disorders the oral dose is preferably 10-200 mg for pigs and 50-500 mg for cattle. For cats and dogs the daily dose is 25-250 mg orally. In an example, epidemic diarrhoea in calves was prevented by treating 10 calves with 100 mg/day of disodium cromoglycate in 100 ml of milk from birth to day 21.
FR7813350A 1977-05-06 1978-05-05 Veterinary use of sodium cromoglycate and analogues - for treating and preventing allergic respiratory and gastrointestinal disorders Granted FR2389376A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB1899577A GB1592968A (en) 1977-05-06 1977-05-06 Method of treating animals
GB2218677 1977-05-26
GB2306777 1977-06-01
GB3384777 1977-08-12

Publications (2)

Publication Number Publication Date
FR2389376A1 true FR2389376A1 (en) 1978-12-01
FR2389376B1 FR2389376B1 (en) 1982-02-19

Family

ID=27448439

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7813350A Granted FR2389376A1 (en) 1977-05-06 1978-05-05 Veterinary use of sodium cromoglycate and analogues - for treating and preventing allergic respiratory and gastrointestinal disorders

Country Status (5)

Country Link
AU (1) AU522209B2 (en)
DE (1) DE2819859A1 (en)
FR (1) FR2389376A1 (en)
IE (1) IE46952B1 (en)
NZ (1) NZ187192A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202015100684U1 (en) 2015-02-12 2015-02-27 Alf Fahrzeugbau Gmbh & Co Kg Mobile treatment facility for animals
IL297023A (en) * 2020-04-06 2022-12-01 Massachusetts Gen Hospital Methods of treatment of coronavirus-induced inflammation conditions

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3686412A (en) * 1965-03-25 1972-08-22 Colin Fitzmaurice Compositions containing bis-chromonyl compounds for inhibiting antigen-antibody reactions
DE2500656A1 (en) * 1975-01-09 1976-07-15 Fisons Ltd Medicaments contg. 1,3-bis-(2-carboxychromone-5-yloxy)-alkanes - for treating gastro-intestinal disorders caused by allergy or immunity

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
DE2448730A1 (en) * 1973-10-23 1975-04-24 Fisons Ltd NEW 4-OXO-4H-1-BENZOPYRANE DERIVATIVES AND METHOD FOR THEIR PRODUCTION
IL46028A0 (en) * 1973-11-21 1975-02-10 Fisons Ltd Novel chromones and xanthones,their preparation and pharmaceutical compositions containing them
GB1488707A (en) * 1974-07-10 1977-10-12 Fisons Ltd 5-(2-hydroxy-propoxy)-4-oxo-8-propyl-4h-1-benzopyran-2-carboxylic acid and derivatives thereof
DE2537204A1 (en) * 1974-08-23 1976-03-04 Fisons Ltd NEW BENZOPYRANES AND THE METHOD OF MANUFACTURING THEM
DE2634908A1 (en) * 1974-11-09 1977-04-14 Fisons Ltd Bis carboxy-chromonyl-oxy alkane compsn.
FR2292468A1 (en) * 1974-11-30 1976-06-25 Fisons Ltd MONOCHROMES

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3686412A (en) * 1965-03-25 1972-08-22 Colin Fitzmaurice Compositions containing bis-chromonyl compounds for inhibiting antigen-antibody reactions
DE2500656A1 (en) * 1975-01-09 1976-07-15 Fisons Ltd Medicaments contg. 1,3-bis-(2-carboxychromone-5-yloxy)-alkanes - for treating gastro-intestinal disorders caused by allergy or immunity

Also Published As

Publication number Publication date
FR2389376B1 (en) 1982-02-19
AU3584278A (en) 1979-11-08
DE2819859A1 (en) 1978-11-09
IE780908L (en) 1978-11-06
NZ187192A (en) 1982-02-23
AU522209B2 (en) 1982-05-20
DE2819859C2 (en) 1989-08-31
IE46952B1 (en) 1983-11-16

Similar Documents

Publication Publication Date Title
HU9301978D0 (en) Application of complementary inhibitors in medical preparatives used for treatment of inflammatory diseases of intestines and skin
Farrer Sprays and lozenges for sore throats
SEGAL Photosensitivity, nail discoloration, and onycholysis: side effects of tetracycline therapy
BRPI0410131A (en) Dietary supplement for use in the treatment and / or inhibition of digestive tract ulcers in horses and other animals and their method
FR2389376A1 (en) Veterinary use of sodium cromoglycate and analogues - for treating and preventing allergic respiratory and gastrointestinal disorders
NL7804843A (en) Veterinary use of sodium cromoglycate and analogues - for treating and preventing allergic respiratory and gastrointestinal disorders
US3928578A (en) Composition for control of white muscle disease
JPH0463861B2 (en)
Khasawneh et al. Morning versus Evening Dose: A Comparison of Three H2--Receptor Blockers in Duodenal Ulcer Healing.
STURNICK et al. Studies on the action of quinidine in man: II. Intramuscular administration of a soluble preparation of quinidine in the treatment of acute cardiac arrhythmias
MUKASA et al. A new double medication method for the treatment of alcoholism using the drug cyanamide
Kingma The pharmacology and toxicology of boron compounds
HK1016408A1 (en) Use of a combination of antineoplastons for the manufacture of a medicament for the treatment of neurofibromatosis
Steven et al. Does the order of second-line treatment in rheumatoid arthritis matter?
Forgan History of the treatment of trichomoniasis.
NZ510885A (en) Use of selamectin to treat parasitic infections in infants by administering it to the female parent before and ending after parturition
US3829566A (en) Method for control of white muscle disease
US3422182A (en) Method of treating an animal having demodectic mange
FR2329260A1 (en) Licking block for administering curative doses of medicaments - esp. anthelmintics, contains organoleptic agents such as sodium chloride and mineral salts
Pomeroy Effects of Datura Stramonium in Tic Douloureux
Moore A month's practice in a small Indian dispensary
Kelly Preliminary observations on a new approach to treatment of peptic ulcer and digestive disorders
Mira et al. Treatment of pharyngitis and pharyngolaryngitis. Comparison of phenylprenazone and flurbiprofen(froben) administered orally and rectally.
Bastedo POINTS IN THE PHARMACOLOGY OF CERTAIN DRUGS USED FOR STOMACH EFFECTS. 1
Fantus et al. The Effect of Salicylates on Experimental Arthritis in Rabbits